(RTTNews) - Harvard Bioscience Inc. (HBIO: News ), a maker of apparatus and scientific instruments used in life science research in pharmaceutical and biotechnology companies, Thursday said it has filed two patents in the field of regenerative medicine.
The first patents covers 61 claims for its stem cell therapy injectors and the second for 338 claims for bioreactors for organ growth.
Harvard Bioscience is collaborating with leading academics in the field of regenerative medicine to develop its regenerative medicine products.
Click here to receive FREE breaking news email alerts for Harvard Bioscience Inc. and others in your portfolio
For comments and feedback: contact editorial@rttnews.com
No comments:
Post a Comment